Cumulative update on pregnancy outcomes after fingolimod treatment in patients with multiple sclerosis

被引：0
|
作者：
Prach, L. M. [1 ]
Moore, A. [1 ]
Rezaallah, B. [1 ]
Mcbride, G. [1 ]
Khan, I. A. [2 ]
Guennec, M. [3 ]
Bhatt, A. [2 ]
Geissbuehler, Y. [1 ]
Leon, S. Lopez [4 ]
Vukusic, S. [5 ]
Butzkueven, H. [6 ]
Tilson, H. [7 ]
Macdonald, T. M. [8 ]
Hellwig, K. [9 ]
机构：
[1] Novartis Pharma AG, Basel, Switzerland
[2] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India
[3] IQVIA, Paris, France
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Hosp Civils Lyon, Hop Neurol, Serv Neurol, Sclerose Plaques Pathol Myeline & Neuroinflammat, Lyon, France
[6] Monash Univ, MS & Neuroimmunol Unit, Cent Clin Sch, Alfred Ctr, Clayton, Vic, Australia
[7] UNC Gillings Sch Global Publ Hlth, Chapel Hill, NC USA
[8] Ninewells Hosp & Med Sch, Dundee, Scotland
[9] Ruhr Univ, St Josef Hosp, Dept Neurol, Bochum, Germany
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1118
引用
收藏
页码：646 / 646
页数：1
相关论文
共 50 条
  • [1] Evaluation of pregnancy outcomes in patients with multiple sclerosis after fingolimod exposure
    Geissbuhler, Yvonne
    Vile, Jere
    Koren, Gideon
    Guennec, Morgane
    Butzkueven, Helmut
    Tilson, Hugh
    MacDonald, Thomas M.
    Hellwig, Kerstin
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [2] Effect of fingolimod on pregnancy outcomes in patients with multiple sclerosis
    Leon, S. Lopez
    Geissbuehler, Y.
    Moore, A.
    Saxena, A.
    Bhatt, A.
    Guennec, M.
    Vukusic, S.
    Butzkueven, H.
    Tilson, H.
    MacDonald, T. M.
    Hellwig, K.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 171 - 172
  • [3] Cumulative data on pregnancy outcomes after exposure to fingolimod
    Hellwig, K.
    Koren, G.
    Butzkueven, H.
    Tilson, H.
    Hernandez-Diaz, S.
    Macdonald, T.
    Kornyeyeva, E.
    Plana, E.
    Lu, Y.
    Cremer, M.
    Amar, R. K.
    Schlosshauer, R.
    Collins, W.
    Geissbuehler, Y.
    Karlsson, G.
    MULTIPLE SCLEROSIS JOURNAL, 2013, 19 (11) : 31 - 32
  • [4] Pregnancy outcomes in patients with multiple sclerosis following maternal exposure to fingolimod
    Geissbuhler, Y.
    Saxena, A.
    Bhatt, A.
    Koren, G.
    Guennec, M.
    Vukusic, S.
    Butzkueven, H.
    Tilson, H.
    Macdonald, T. M.
    Hellwig, K.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 501 - 501
  • [5] Neurovascular reactivity after Fingolimod treatment in patients with multiple sclerosis
    Uzuner, Gulnur Tekgol
    Uzuner, Nevzat
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 917 - 918
  • [6] Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis
    Karlsson, Goeril
    Francis, Gordon
    Koren, Gideon
    Heining, Peter
    Zhang, Xiaoli
    Cohen, Jeffrey A.
    Kappos, Ludwig
    Collins, William
    NEUROLOGY, 2014, 82 (08) : 674 - 680
  • [7] Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis
    Gunduz, Tuncay
    Kurtuncu, Murat
    Eraksoy, Mefkure
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 11 : 1 - 3
  • [8] Rebound Syndrome In Patients With Multiple Sclerosis After Stopping Fingolimod Treatment
    Diaz-Perez, C.
    Meca-Lallana, V.
    Aguirre, C.
    Del Rio, B.
    Carabajal, E.
    Martin Villalba, R.
    Vivancos, J.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 101 - 102
  • [9] Rebound Syndrome in Patients With Multiple Sclerosis After Cessation of Fingolimod Treatment
    Hatcher, Stacy Ellen
    Waubant, Emmanuelle
    Nourbakhsh, Bardia
    Crabtree-Hartman, Elizabeth
    Graves, Jennifer S.
    JAMA NEUROLOGY, 2016, 73 (07) : 790 - 794
  • [10] Fingolimod for relapsing multiple sclerosis: an update
    Horga, Alejandro
    Castillo, Joaquin
    Montalban, Xavier
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (07) : 1183 - 1196
12345